Sun Pharma Shares Tumble 4% as Firm Closes in on $12-Billion Organon Acquisition. What’s Spooking Investors?
Sun Pharmaceutical Industries, India’s largest drugmaker, saw its shares fall nearly 4% as news broke that the company is closing in on a $12-billion acquisition of US-based Organon. While the deal could potentially transform Sun Pharma into a global pharmaceutical powerhouse, investor sentiment has turned cautious, reflecting concerns about debt, integration risks, and market volatility….